Key result
In a prospective cohort of 270 patients with coronary heart disease, neural network analysis of blood TNF levels was evaluated to identify the risk of recurrent coronary syndrome and mortality.
Why the study?
It was unclear whether higher TNF levels found months after a myocardial infarction are associated with an increased risk of subsequent heart attacks.
Do blood Tumour Necrosis Factor (TNF) levels correlate with recurrent coronary syndrome and coronary mortality in patients with coronary heart disease?
Cohort (n=270)
Do blood Tumour Necrosis Factor (TNF) levels correlate with recurrent coronary syndrome and coronary mortality in patients with coronary heart disease?
Computational neural network analysis of blood TNF levels may help identify the risk of recurrent coronary events and mortality in patients with coronary heart disease.
TNF levels may associate with recurrent events in CHD; hypothesis-generating for neural network prediction, requires prospective validation.
Tumour necrosis factor (TNF) levels are higher in patients who have experienced an acute ischemic stroke. Greater levels of TNF may not be linked to an increased risk of recurrent coronary events in the stable phase after myocardial ischemia (MI). Coronary atheroma is connected to endothelial and smooth muscle cells, as well as macrophages that emit the multifunctional cytokine tumour necrosis factor (TNF). Transplanted tumours become more vulnerable when TNF-α was first recognized to have a function in hemorrhagic necrosis. TNF-α has been demonstrated to induce heart failure, pulmonary edoema, and cardiomyopathy in people with advanced heart failure when it is elevated in the bloodstream. It has been postulated that prolonged overexpression of TNF-α after ischemia may contribute to poor cardiac outcomes by increasing TNF-α when the myocardium undergoes both temporary ischemia and reperfusion. A rise in TNF levels has been seen after a myocardial infarction, but it is unclear if these higher levels, found months after the initial event, are associated with an increased risk of subsequent heart attacks. We looked at TNF levels in the blood of 270 patients with coronary heart disease in the Chinese Hypertension League’s Cholesterol and Recurrent Events (CARE) experiment to see if this notion held true. Recurrent coronary syndrome and coronary mortality were monitored prospectively in the participants. The min max imbalance normalization can be used to assess a patient’s baseline characteristics, including hormone and cholesterol test results. Type 2 stimulant connection to aggregate the TNF-signaling qualities and fuzzy techniques was applied. There may now be enough preliminary evidence from the crucial bundle neural network analysis to identify the risk of coronary heart disease associated with TNF pregeneration studies. The tests were assessed using a variety of methods and performance metrics in a Matlab environment.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2022) conducted a cohort in Coronary heart disease (n=270). Tumour necrosis factor (TNF) levels was evaluated on Recurrent coronary syndrome and coronary mortality. In a prospective cohort of 270 patients with coronary heart disease, neural network analysis of blood TNF levels was evaluated to identify the risk of recurrent coronary syndrome and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: